Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam versus normal saline for hemodynamic response during tracheal intubation in elderly cataract surgery patients
IRCT20200510047389N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine and midazolam in cataract (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Hemodynamic responses. Started Nov 2018; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20200510047389N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200510047389N2.